Research Article
Expression of TNF-α, April and BCMA in Behcet’s Disease
Table 2
Laboratory data of patients and controls.
| | Cases | Controls | value | | Range | Mean ± standard deviation | Range | Mean ± standard deviation |
| ESR (mm/hr) | 3–100 | 30.8 ± 26.5 | 2–10 | 6.3 ± 2.56 | 0.001 | hs-CRP (ug/dL) | 1.7–30 | 14.3 ± 10.4 | 1.11–10.4 | 4.9 ± 3.15 | 0.001 | TNF- (pg/dL) | 2.3–58.9 | 31 ± 16.8 | 1.4–13.9 | 5.08 ± 3.19 | 0.001 | APRIL (ng/mL) | 1.64–20.8 | 8.69 ± 4.9 | 1.02–6.04 | 3.13 ± 1.52 | 0.001 | BAFF (Pg/mL) | 177–914.9 | 391.83 ± 145.55 | 109–398 | 243.6 ± 81.16 | 0.001 | BCMA (ng/mL) | 1.04–27.1 | 14.1 ± 6.6 | 1–3.89 | 2.06 ± 0.71 | 0.001 |
|
|
ESR: erythrocyte sedimentation rate, hs-CRP: highly sensitive C-reactive protein, TNF-α: tumor necrosis factor alpha, BCMA: C cell maturation antigen, APRIL: a proliferation inducing ligand, and BAFF: B cell activation factor.
|